Subtype
Malignant Biliary Tract Neoplasm
CI-CAN-00003139Explore in graph →
366 active trials6 approved drugs33 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003139Explore in graph →
Clinical trials
1,281 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (152)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02597465 | A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507 | withdrawn | Phase 3 | 0 | Sun Pharma Advanced Research Company LimitedINDUSTRY | 1 | Dec 14, 2020 | clinicaltrials |
| NCT03579758 | Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer | withdrawn | Phase 3 | 0 | Emory UniversityOTHER | 1 | Jun 5, 2020 | clinicaltrials |
| NCT03081039 |
| A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma |
| withdrawn |
| Phase 3 |
| 0 |
| University of LouisvilleOTHER |
| 1 |
| Feb 19, 2018 |
| clinicaltrials |
| NCT00253617 | Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 2 | Apr 4, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Dec 14, 2020source: clinicaltrials